Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 19 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort studyOwen, C.; Ngian, G.; Elford, K.; Moore, O.; Stevens, W.; Nikpour, M.; Rabusa, C.; Proudman, S.; Roddy, J.; Zochling, J.; Hill, C.; Sturgess, A.; Tymms, K.; Youssef, P.; Sahhar, J.
2010Thrombolysis for acute stroke in Australia: outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008)Simpson, M.; Dewey, H.; Churilov, L.; Ahmed, N.; Bladin, C.; Schultz, D.; Markus, R.; Sturm, J.; Levi, C.; Blacker, D.; Jannes, J.; Lindley, R.; Parsons, M.
2016Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): An open-label randomised, controlled trialZdenkowski, N.; Forbes, J.F.; Boyle, F.M.; Kannourakis, G.; Gill, P.G.; Bayliss, E.; Saunders, C.; Della-Fiorentina, S.; Kling, N.; Campbell, I.; Mann, G.B.; Coates, A.S.; Gebski, V.; Davies, L.; Thornton, R.; Reaby, L.; Cuzick, J.; Green, M.
2019Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trialAnderson, C.S.; Huang, Y.; Lindley, R.I.; Chen, X.; Arima, H.; Chen, G.; Li, Q.; Billot, L.; Delcourt, C.; Bath, P.M.; Broderick, J.P.; Demchuk, A.M.; Donnan, G.A.; Durham, A.C.; Lavados, P.M.; Lee, T.H.; Levi, C.; Martins, S.O.; Olavarria, V.V.; Pandian, J.D.; et al.
2019Investigating Dimensions of Stiffness in Rheumatoid and Psoriatic Arthritis: The Australian Rheumatology Association Database Registry and OMERACT CollaborationSinnathurai, P.; Bartlett, S.J.; Halls, S.; Hewlett, S.; Orbai, A.M.; Buchbinder, R.; Henderson, L.; Hill, C.L.; Lassere, M.; March, L.
2019Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companiesBoudville, N.; Ullah, S.; Clayton, P.; Sud, K.; Borlace, M.; Badve, S.V.; Chakera, A.; Johnson, D.W.
2019Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort studyHenderson, A.; Harris, P.; Hartel, G.; Paterson, D.; Turnidge, J.; Davis, J.S.; Tong, S.Y.C.
2015Frailty in nursing homes: the FRAIL-NH scaleKaehr, E.; Visvanathan, R.; Malmstrom, T.K.; Morley, J.E.
2013Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomesCho, Y.; Badve, S.; Hawley, C.; McDonald, S.; Brown, F.; Boudville, N.; Bannister, K.; Clayton, P.; Johnson, D.
2013Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS StudyChew, D.; French, J.; Briffa, T.; Hammett, C.; Ellis, C.; Ranasinghe, I.; Aliprandi-Costa, B.; Astley, C.; Turnbull, F.; Lefkovits, J.; Redfern, J.; Carr, B.; Gamble, G.; Lintern, K.; Howell, T.; Parker, H.; Tavella, R.; Bloomer, S.; Hyun, K.; Brieger, D.